Baduanjin With Resistance Training Program

Launched by YALE UNIVERSITY · Feb 24, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a special exercise program called Baduanjin, combined with resistance training, to help people with Lumbar Disc Herniation (a painful back condition) and Osteoporosis (a disease that weakens bones). The goal is to see if this exercise can reduce pain, improve muscle strength, and enhance the quality of life for older Chinese patients who have these conditions.

To be eligible for this study, you need to be a woman aged 45 or older or a man aged 50 or older who has been diagnosed with Lumbar Disc Herniation and Osteoporosis. You should also be experiencing some pain, as measured on a scale where 3 points or higher indicates discomfort. Participants should be able to speak Mandarin and must not have any serious health issues or have engaged in regular physical activity recently. If you join this trial, you will take part in the exercise program during your stay in the hospital, and it could provide valuable insights into how exercise can help improve symptoms for elderly patients like you.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients diagnosed with LDH and OP based on the chart and clinical diagnostic criteria.
• • Age of female patients ≥ 45 years，age of male patients ≥ 50 years.
• • Visual analogue scale (VAS) ≥ 3 points.
• • Surgical operation will be performed during the 7-day admission period.
• • Mandarin speakers.
• Exclusion Criteria:
• • Severe primary diseases: ulcerative colitis, gastrointestinal bleeding, pancreatitis, lung cancer, pneumonia, acute respiratory distress syndrome or psychosis, depression, anxiety or substance abuse, identified by diagnosis and interview.
• • Current engagement in regular physical activity routines over the past 3 months: aerobic exercises for at least 30 minutes, at least 3 times per week.
• • Taken drugs within 3 months before enrollment: bisphosphonates, glucocorticoids, calcitonin, anticonvulsant drugs, heparin, etc.